-
201
Primary Sarcoma of the Specialised Prostatic Stroma: A Case Report and Review of the Literature
Published 2011-01-01“…Primary sarcoma tumours of the prostate are rare and are classified, according to their histology, as stromal tumours of uncertain malignant potential (STUMP) and stromal prostatic sarcoma (PS; low and high grade). …”
Get full text
Article -
202
Development and test of reliability and validity of the Health Belief Scale for Prostate Cancer Screening
Published 2025-01-01Subjects: “…prostate cancer…”
Get full text
Article -
203
Characterizing ProstivaTM RF Treatments of the Prostate for BPH with Gadolinium-Enhanced MRI
Published 2009-01-01“…Transurethral needle ablation (TUNA) is an accepted and effective therapy for the treatment of lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). ProstivaTM (Medtronic, Shoreview, MN) is the newest-generation device, which includes a new needle design and radio frequency (RF) generator. …”
Get full text
Article -
204
Bone-Targeted Therapies in Metastatic Castration-Resistant Prostate Cancer: Evolving Paradigms
Published 2013-01-01“…Prostate Cancer…”
Get full text
Article -
205
Synergistic Effect of Geranylgeranyltransferase Inhibitor, GGTI, and Docetaxel on the Growth of Prostate Cancer Cells
Published 2012-01-01“…Prostate Cancer…”
Get full text
Article -
206
Inverse Relationship Between Leydig Cell Density and Metastatic Potential of Prostatic Adenocarcinoma
Published 1999-01-01“…Purpose: Evaluate the relationship between metastatic potential of prostatic adenocarcinoma (PC) and testicular Leydig cell density. …”
Get full text
Article -
207
Global Patterns of Prostate Cancer Incidence, Aggressiveness, and Mortality in Men of African Descent
Published 2013-01-01“…Prostate Cancer…”
Get full text
Article -
208
Mitochondrial Cytochrome c Oxidase Subunit 1 Sequence Variation in Prostate Cancer
Published 2012-01-01“…Mitochondrial DNA (mtDNA) mutations have been described in every adult neoplasm including prostate cancer. There are marked racial differences in mutations within the cytochrome c oxidase subunit 1 (COI) gene in individuals with prostate cancer (PCa). …”
Get full text
Article -
209
Targeting Bone Metabolism in Patients with Advanced Prostate Cancer: Current Options and Controversies
Published 2015-01-01“…Maintaining bone health remains a clinical challenge in patients with prostate cancer (PC) who are at risk of developing metastatic bone disease and increased bone loss due to hormone ablation therapy. …”
Get full text
Article -
210
Docetaxel-Induced Stevens-Johnson Syndrome in a Patient with Metastatic Prostate Adenocarcinoma
Published 2019-01-01“…We present a case of apparent docetaxel-induced Stevens-Johnson syndrome (SJS) in a patient recently treated for metastatic prostate cancer. This medication is not classically associated with the development of SJS but in our case, along with a number of other case reports, and a single phase II clinical trial, an association was recognized. …”
Get full text
Article -
211
It Suddenly Occurred: Extensive Subcutaneous Emphysema after Bipolar Transurethral Resection of Prostate
Published 2015-01-01“…We report the first case of a wide subcutaneous emphysema due to microperforations of prostatic capsule, without a bladder perforation after TURP. …”
Get full text
Article -
212
Androgen receptor dynamics in prostate cancer: from disease progression to treatment resistance
Published 2025-02-01Subjects: “…prostate cancer…”
Get full text
Article -
213
A Perspective on Withania somnifera Modulating Antitumor Immunity in Targeting Prostate Cancer
Published 2021-01-01“…This article signifies the cumulative information about the role of WFA in modulating antitumor immunity and its potential in targeting prostate cancer.…”
Get full text
Article -
214
Mathematical modeling of continuous and intermittent androgen suppression for the treatment of advanced prostate cancer
Published 2017-05-01Subjects: “…prostate cancer…”
Get full text
Article -
215
Biomarker-Based Targeting of the Androgen-Androgen Receptor Axis in Advanced Prostate Cancer
Published 2012-01-01“…Recent therapeutic advances for managing advanced prostate cancer include the successful targeting of the androgen-AR axis with several new drugs in castrate resistant prostate cancer including abiraterone acetate and enzalutamide (MDV3100). …”
Get full text
Article -
216
Urodynamic Evaluation after High-Intensity Focused Ultrasound for Patients with Prostate Cancer
Published 2014-01-01“…Prostate Cancer…”
Get full text
Article -
217
Prostate Cancer-Associated Disseminated Intravascular Coagulation with Excessive Fibrinolysis Treated with Degarelix
Published 2015-01-01“…Disseminated intravascular coagulation (DIC) with excessive fibrinolysis (XFL) is a rare and acute life-threatening variant of DIC in patients with prostate cancer. Patients present with coagulopathy, hypofibrinogenemia, and systemic bleeding. …”
Get full text
Article -
218
Investigating the Role of Osteopontin (OPN) in the Progression of Breast, Prostate, Renal and Skin Cancers
Published 2025-01-01Subjects: Get full text
Article -
219
Trends in incidence and mortality of prostate cancer in Ningbo City from 2011 to 2023
Published 2025-01-01Subjects: “…prostate cancer…”
Get full text
Article -
220
Prognostic value of intraductal carcinoma subtypes and postoperative radiotherapy for localized prostate cancer
Published 2025-01-01Subjects: “…Prostate cancer…”
Get full text
Article